Literature DB >> 32267622

T-cell targeted pulmonary siRNA delivery for the treatment of asthma.

Tobias W M Keil1, Domizia Baldassi1, Olivia M Merkel1.   

Abstract

Despite the large number of drugs available for the treatment of asthma, in 5-10% of the patients this disease is not well controlled. While most treatments palliate symptoms, those suffering from severe and uncontrolled asthma could benefit more from a therapeutic approach addressing the root problem. An siRNA-based therapy targeting the transcription factor GATA3 in activated T helper cells subtype 2 (TH 2 cells), one of the key upstream factors involved in asthma, could therefore represent a promising strategy. However, the difficult-to-transfect cell type has not extensively been explored for nucleic acid therapeutics. In this regard, our group first identified a suitable pathway, that is, transferrin receptor mediated uptake, to target efficiently and specifically activated TH 2 cells with a transferrin-polyethyleneimine (PEI) conjugate which forms polyplexes with siRNA. This system, despite efficient uptake in activated T cells (ATCs) in vivo, suffered from poor endosomal release and was later improved by a combination with a melittin-PEI conjugate. The new formulation showed improved endosomal escape and gene silencing efficacy. Additionally, in order to develop a clinically relevant dosage form for pulmonary delivery of siRNA we have lately focused on a dry powder formulation by spray drying (SD) for the production of inhalable nano-in-microparticles. In proof-of-concept experiments, DNA/PEI polyplexes were used in order to implement analytics and engineer process parameters to pave the way for SD also siRNA containing polyplexes and more sophisticated systems in general. Ultimately, our efforts are devoted to the development of a novel treatment of asthma that can be translated from bench to bedside and are reviewed and discussed here in the context of the current literature. This article is categorized under: Therapeutic Approaches and Drug Discovery > Nanomedicine for Respiratory Disease Biology-Inspired Nanomaterials > Nucleic Acid-Based Structures Biology-Inspired Nanomaterials > Protein and Virus-Based Structures.
© 2020 The Authors. WIREs Nanomedicine and Nanobiotechnology published by Wiley Periodicals, Inc.

Entities:  

Keywords:  T cells; asthma; inhalation; siRNA

Year:  2020        PMID: 32267622      PMCID: PMC7116616          DOI: 10.1002/wnan.1634

Source DB:  PubMed          Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol        ISSN: 1939-0041


  48 in total

1.  Development of spray-freeze-dried siRNA/PEI powder for inhalation with high aerosol performance and strong pulmonary gene silencing activity.

Authors:  Tomoyuki Okuda; Masaki Morishita; Kimiyasu Mizutani; Ayumi Shibayama; Maki Okazaki; Hirokazu Okamoto
Journal:  J Control Release       Date:  2018-04-06       Impact factor: 9.776

2.  Cationic polymers for non-viral gene delivery to human T cells.

Authors:  Brynn R Olden; Yilong Cheng; Jonathan L Yu; Suzie H Pun
Journal:  J Control Release       Date:  2018-03-05       Impact factor: 9.776

3.  Spray-Dried Nanoparticle-in-Microparticle Delivery Systems (NiMDS) for Gene Delivery, Comprising Polyethylenimine (PEI)-Based Nanoparticles in a Poly(Vinyl Alcohol) Matrix.

Authors:  Jan Schulze; Stephanie Kuhn; Stephan Hendrikx; Michaela Schulz-Siegmund; Tobias Polte; Achim Aigner
Journal:  Small       Date:  2018-02-12       Impact factor: 13.281

Review 4.  Solid Lipid Nanoparticles (SLN) and Nanostructured Lipid Carriers (NLC) for pulmonary application: a review of the state of the art.

Authors:  S Weber; A Zimmer; J Pardeike
Journal:  Eur J Pharm Biopharm       Date:  2013-09-02       Impact factor: 5.571

5.  Identifying key barriers in cationic polymer gene delivery to human T cells.

Authors:  Brynn R Olden; Emmeline Cheng; Yilong Cheng; Suzie H Pun
Journal:  Biomater Sci       Date:  2019-02-26       Impact factor: 6.843

Review 6.  Pulmonary gene delivery using polymeric nonviral vectors.

Authors:  Olivia M Merkel; Mengyao Zheng; Heiko Debus; Thomas Kissel
Journal:  Bioconjug Chem       Date:  2011-11-01       Impact factor: 4.774

7.  Critical link between TRAIL and CCL20 for the activation of TH2 cells and the expression of allergic airway disease.

Authors:  Markus Weckmann; Adam Collison; Jodie L Simpson; Matthias V Kopp; Peter A B Wark; Mark J Smyth; Hideo Yagita; Klaus I Matthaei; Nicole Hansbro; Bruce Whitehead; Peter G Gibson; Paul S Foster; Joerg Mattes
Journal:  Nat Med       Date:  2007-10-14       Impact factor: 53.440

8.  Coming in and Finding Out: Blending Receptor-Targeted Delivery and Efficient Endosomal Escape in a Novel Bio-Responsive siRNA Delivery System for Gene Knockdown in Pulmonary T Cells.

Authors:  Rima Kandil; Yuran Xie; Ralf Heermann; Lorenz Isert; Kirsten Jung; Aditi Mehta; Olivia M Merkel
Journal:  Adv Ther (Weinh)       Date:  2019-04-26

9.  In vitro and in vivo delivery of siRNA via VIPER polymer system to lung cells.

Authors:  Daniel P Feldmann; Yilong Cheng; Rima Kandil; Yuran Xie; Mariam Mohammadi; Hartmann Harz; Akhil Sharma; David J Peeler; Anna Moszczynska; Heinrich Leonhardt; Suzie H Pun; Olivia M Merkel
Journal:  J Control Release       Date:  2018-02-20       Impact factor: 9.776

10.  Spray drying of siRNA-containing PLGA nanoparticles intended for inhalation.

Authors:  Ditte Marie Krohn Jensen; Dongmei Cun; Morten Jonas Maltesen; Sven Frokjaer; Hanne Mørck Nielsen; Camilla Foged
Journal:  J Control Release       Date:  2009-10-22       Impact factor: 9.776

View more
  8 in total

Review 1.  Tissue-specific immunity for a changing world.

Authors:  Stuart P Weisberg; Basak B Ural; Donna L Farber
Journal:  Cell       Date:  2021-03-18       Impact factor: 41.582

Review 2.  Inhaled RNA Therapeutics for Obstructive Airway Diseases: Recent Advances and Future Prospects.

Authors:  You Xu; Aneesh Thakur; Yibang Zhang; Camilla Foged
Journal:  Pharmaceutics       Date:  2021-01-28       Impact factor: 6.321

Review 3.  siRNA Therapeutics against Respiratory Viral Infections-What Have We Learned for Potential COVID-19 Therapies?

Authors:  Aditi Mehta; Thomas Michler; Olivia M Merkel
Journal:  Adv Healthc Mater       Date:  2021-01-27       Impact factor: 11.092

Review 4.  The biological applications of DNA nanomaterials: current challenges and future directions.

Authors:  Wenjuan Ma; Yuxi Zhan; Yuxin Zhang; Chenchen Mao; Xueping Xie; Yunfeng Lin
Journal:  Signal Transduct Target Ther       Date:  2021-10-08

Review 5.  Inhaled siRNA Formulations for Respiratory Diseases: From Basic Research to Clinical Application.

Authors:  Yulin Fan; Zhijun Yang
Journal:  Pharmaceutics       Date:  2022-06-02       Impact factor: 6.525

Review 6.  Inhaled RNA Therapy: From Promise to Reality.

Authors:  Michael Y T Chow; Yingshan Qiu; Jenny K W Lam
Journal:  Trends Pharmacol Sci       Date:  2020-09-04       Impact factor: 14.819

Review 7.  Melittin-Based Nano-Delivery Systems for Cancer Therapy.

Authors:  Anqi Wang; Yuan Zheng; Wanxin Zhu; Liuxin Yang; Yang Yang; Jinliang Peng
Journal:  Biomolecules       Date:  2022-01-12

Review 8.  Delivery of mRNA for regulating functions of immune cells.

Authors:  Jia Shi; Meng-Wen Huang; Zi-Dong Lu; Xiao-Jiao Du; Song Shen; Cong-Fei Xu; Jun Wang
Journal:  J Control Release       Date:  2022-03-23       Impact factor: 11.467

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.